Joseph Baroldi - Jan 15, 2023 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
EVP, Chief Business Officer
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Joseph T. Baroldi
Stock symbol
IONS
Transactions as of
Jan 15, 2023
Transactions value $
$0
Form type
4
Date filed
1/18/2023, 07:15 PM
Previous filing
Jan 5, 2023
Next filing
Jan 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IONS Performance Restricted Stock Units Award $0 +12.3K $0.00 12.3K Jan 15, 2023 Common Stock 12.3K $0.00 Direct F1, F2
transaction IONS Restricted Stock Unit Award $0 +14.7K +34.02% $0.00 58.1K Jan 15, 2023 Common Stock 14.7K $0.00 Direct F3, F4, F5
transaction IONS Restricted Stock Unit Award $0 +1.8K +58.71% $0.00 4.87K Jan 15, 2023 Common Stock 1.8K $0.00 by Spouse F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant to reporting person of Performance Restricted Stock Units under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan.
F2 Represents an award of performance based restricted stock units ("PRSUs"). The PRSUs may vest at the end of the three-year performance period following the date of grant based on the Issuer's relative total shareholder return as compared to a peer group of companies. The number of PRSUs reported represents the maximum that may be earned, which is 200% of the target number. No number of PRSUs is guaranteed to vest and the actual number of PRSUs that will vest at the end of the performance period may be anywhere from zero to the amount stated.
F3 Grant to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan.
F4 Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
F5 Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.
F6 Grant to reporting person's spouse of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan.